NCT00736255: Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study |
|
|
| Completed | N/A | 32 | US | Transdermal Nicotine Patch, Nicotine Patch, Lis-dexamphetamine (Vyvanse), LDX and Transdermal Nicotine Patch, Placebo, Placebo and Transdermal Nicotine Patch | Duke University, Shire | Attention Deficit Hyperactivity Disorder, Nicotine Dependence | 07/11 | 07/11 | | |
NCT01263548: To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder |
|
|
| Completed | N/A | 45 | Canada | lisdexamfetamine dimesylate, Vyvanse | University Health Network, Toronto, Shire | Attention Deficit/Hyperactivity Disorder, Bipolar Disorder | 01/12 | 01/12 | | |